We are live on ! Find out more
TRDA icon

Entrada Therapeutics

97 hedge funds and large institutions have $481M invested in Entrada Therapeutics in 2024 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 42 increasing their positions, 18 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

175% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 8

133% more repeat investments, than reductions

Existing positions increased: 42 | Existing positions reduced: 18

110% more call options, than puts

Call options by funds: $551K | Put options by funds: $262K

17% more funds holding

Funds holding: 8397 (+14)

14% more capital invested

Capital invested by funds: $423M → $481M (+$58.3M)

1.01% more ownership

Funds ownership: 79.9%80.91% (+1%)

0% more funds holding in top 10

Funds holding in top 10: 44 (0)

Holders
97
Holders Change
+14
Holders Change %
+16.87%
% of All Funds
1.39%
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.06%
New
22
Increased
42
Reduced
18
Closed
8
Calls
$551K
Puts
$262K
Net Calls
+$289K
Net Calls Change
+$288K
Name Holding Trade Value Shares
Change
Change in
Stake
Man Group
101
Man Group
United Kingdom
-$246K -17,249 Closed
Walleye Capital
102
Walleye Capital
New York
-$190K -13,323 Closed
CIC
103
Cornercap Investment Counsel
Georgia
-$185K -13,014 Closed
PIM
104
Plato Investment Management
Australia
-$869 -61 Closed
AACP
105
Advantage Alpha Capital Partners
California
-$285 -20 Closed